Location History:
- Lindenhurst, NY (US) (2017)
- New York, NY (US) (2017)
Company Filing History:
Years Active: 2017
Title: Paul H Naylor: Innovator in Vaccine Immunotherapy
Introduction
Paul H Naylor is a notable inventor based in Lindenhurst, NY (US). He has made significant contributions to the field of cancer treatment through his innovative work in vaccine immunotherapy. With a total of 2 patents, Naylor is dedicated to advancing medical science and improving patient outcomes.
Latest Patents
Naylor's latest patents focus on a composition for treating cancer that includes synergistic amounts of a primary cell-derived biologic. This biologic contains various cytokines such as IL-1, IL-2, IL-6, IL-8, TNF-α, and IFN-γ, combined with a cancer vaccine that has at least one antigen. His methods include treating cancer by administering this composition, reversing immune suppression, and enhancing immune responses in patients. These innovative approaches aim to increase the function of the immune system and provide new avenues for cancer treatment.
Career Highlights
Naylor is currently associated with Irx Therapeutics, Inc., where he continues to develop groundbreaking therapies. His work is characterized by a commitment to harnessing the body's immune response to combat cancer effectively.
Collaborations
Some of his notable coworkers include John W Hadden and Kathy L Signorelli, who contribute to the collaborative efforts in advancing cancer immunotherapy.
Conclusion
Paul H Naylor's contributions to vaccine immunotherapy represent a significant advancement in cancer treatment. His innovative patents and dedication to research continue to inspire progress in the medical field.